| Absorption |
| Blood-Brain Barrier | BBB+ | 0.8841 |
| Human Intestinal Absorption | HIA+ | 1.0000 |
| Caco-2 Permeability | Caco2+ | 0.8005 |
| P-glycoprotein Substrate | Non-substrate | 0.6445 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.9118 |
| Non-inhibitor | 0.9326 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.8772 |
| Distribution |
| Subcellular localization | Mitochondria | 0.8429 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.7743 |
| CYP450 2D6 Substrate | Non-substrate | 0.9257 |
| CYP450 3A4 Substrate | Non-substrate | 0.7388 |
| CYP450 1A2 Inhibitor | Inhibitor | 0.9387 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.5514 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.8045 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.6779 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.9408 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.8457 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9380 |
| Non-inhibitor | 0.9357 |
| AMES Toxicity | AMES toxic | 0.9231 |
| Carcinogens | Non-carcinogens | 0.8850 |
| Fish Toxicity | High FHMT | 0.9528 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9608 |
| Honey Bee Toxicity | High HBT | 0.7497 |
| Biodegradation | Not ready biodegradable | 0.6654 |
| Acute Oral Toxicity | III | 0.4672 |
| Carcinogenicity (Three-class) | Warning | 0.5482 |